Indian Pharma’s ‘Sema’ Storm: Over 50 Semaglutide Brands Queue Up As Ozempic Patent Expires

[ad_1] Last Updated:March 06, 2026, 12:54 IST From Semaglip, Sematop, Semakind to Semastrike, Semaglyn and Semaril, the pipeline of upcoming Ozempic copycats reads like variations of the semaglutide molecule itself Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. File pic/Reuters If there is one prefix that is likely to … Read more

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

[ad_1] Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee … Read more

What Nearly Brainless Rodents Know About Weight Loss and Hunger

[ad_1] Do we really have free will when it comes to eating? It’s a vexing question that is at the heart of why so many people find it so difficult to stick to a diet. To get answers, one neuroscientist, Harvey J. Grill of the University of Pennsylvania, turned to rats and asked what would … Read more